Buy Increlex 10mg/ml Solution For Injection Online At Equines Vet

Increlex 10 mg/mL Solution for Injection is a prescription medicine containing mecasermin (recombinant human IGF-1) for the treatment of growth failure associated with severe primary IGF-1 deficiency in appropriately diagnosed pediatric patients. Administered by subcutaneous injection under specialist medical supervision, Increlex replaces deficient IGF-1 and supports the physiological processes involved in normal growth. Because the medicine can cause hypoglycemia and serious hypersensitivity reactions, treatment requires careful dosing, appropriate meal timing, monitoring, and medical follow-up.

Increlex 10 mg/mL Solution for Injection

Prescription Mecasermin Treatment for Severe Primary IGF-1 Deficiency

Increlex 10 mg/mL Solution for Injection contains mecasermin, a recombinant form of human insulin-like growth factor-1 (IGF-1). IGF-1 is an important hormone involved in normal growth and development. Increlex is a specialized prescription medicine used under the supervision of physicians experienced in diagnosing and treating pediatric growth disorders.

Increlex is specifically indicated for the long-term treatment of growth failure in pediatric patients with severe primary insulin-like growth factor-1 deficiency (Primary IGFD). In the United States, its labeling also includes children aged 2 years and older with growth hormone (GH) gene deletion who have developed neutralizing antibodies to GH. It is not a substitute for growth hormone for conditions in which GH is an approved treatment.

The medicine works by replacing IGF-1 that is insufficiently available in patients with severe primary IGF-1 deficiency. Unlike products intended for general supplementation or cosmetic purposes, Increlex is a clinically indicated medicine for a specific, diagnosed medical condition.

Product Overview

The European Medicines Agency lists Increlex as a 10 mg/mL solution for subcutaneous injection, supplied in a 4 mL glass vial. The U.S. prescribing information likewise identifies the product as a 40 mg/4 mL (10 mg/mL) solution supplied in a multiple-dose vial.

What Is Mecasermin?

Mecasermin is a recombinant form of human IGF-1. IGF-1 naturally works alongside growth hormone and plays an important role in stimulating growth of tissues throughout the body. It promotes cellular growth and division and supports the uptake of nutrients required for normal tissue development.

In patients with severe primary IGF-1 deficiency, the body does not produce or respond to IGF-1 normally despite adequate growth hormone activity. This can result in significant growth failure. Mecasermin provides replacement IGF-1 to help address this specific deficiency.

Because of its pharmacological activity, mecasermin can also have insulin-like effects on blood glucose. This is one reason treatment requires appropriate medical supervision and careful attention to food intake around administration.

What Is Increlex Used For?

Increlex is used for the long-term treatment of growth failure associated with severe primary IGF-1 deficiency.

The EMA defines severe primary IGF-1 deficiency using clinical and laboratory criteria that include markedly reduced height relative to age, low basal IGF-1 levels, adequate growth hormone production, and exclusion of secondary causes of IGF-1 deficiency.

The FDA-approved indication covers pediatric patients aged 2 years and older with severe primary IGF-1 deficiency or, in specified circumstances, growth hormone gene deletion accompanied by neutralizing antibodies to growth hormone.

This makes Increlex fundamentally different from products marketed simply as “growth peptides.” Its use requires a medical diagnosis and individualized clinical assessment.

How Increlex Works

Normal childhood growth involves a complex interaction between growth hormone, IGF-1, nutrition, genetics, and other physiological factors.

Growth hormone stimulates the production of IGF-1, while IGF-1 contributes directly to cellular growth and tissue development. When a child has severe primary IGF-1 deficiency, this pathway is disrupted.

Mecasermin acts as replacement IGF-1. Once administered, it can stimulate biological processes associated with growth and development. The EMA explains that mecasermin works in the same general way as naturally occurring IGF-1 by stimulating cells to divide and grow and supporting nutrient uptake.

Administration and Medical Supervision

Increlex is administered subcutaneously, rather than intravenously. Injection sites should be rotated to reduce the risk of local tissue changes such as lipohypertrophy.

The U.S. prescribing information recommends an initial dose of 0.04–0.08 mg/kg twice daily, with gradual adjustment when tolerated up to a maximum of 0.12 mg/kg twice daily. The EMA product information similarly describes weight-based dosing.

Because dosing is individualized and the medicine can produce hypoglycemia, patients should follow the prescribing physician’s instructions precisely. Increlex should be administered shortly before or after a meal or snack, and treatment should be interrupted if the patient cannot eat.

Important Safety Information

Increlex can cause hypoglycemia, because mecasermin has insulin-like effects. Symptoms of low blood sugar can include dizziness, weakness, sweating, confusion, unusual behavior, or loss of consciousness. Appropriate medical instructions should be provided to patients and caregivers before treatment.

Hypersensitivity reactions, including serious allergic reactions and anaphylaxis, have also been reported. Patients and caregivers should understand the symptoms of serious allergic reactions and seek immediate medical attention if they occur.

The medicine is contraindicated in patients with known hypersensitivity to mecasermin, closed epiphyses, or malignant neoplasia. The EMA likewise notes that Increlex must not be used where active neoplasia is present.

Other clinically important warnings include intracranial hypertension, lymphoid tissue hypertrophy, slipped capital femoral epiphysis, and progression of pre-existing scoliosis. These risks make specialist medical monitoring an essential component of treatment.

Common Adverse Reactions

Reported adverse reactions associated with Increlex include:

• Hypoglycemia
• Injection-site reactions or hypertrophy
• Headache
• Vomiting
• Hypersensitivity reactions
• Tonsillar hypertrophy
• Middle-ear infection

The precise adverse-effect profile depends on the patient and treatment circumstances. The official prescribing information and patient information should be consulted for comprehensive safety details.

Why Accurate Product Information Matters

Increlex is a specialized medicine for a rare endocrine growth disorder. It should not be promoted as a general-purpose treatment for short stature, anti-aging therapy, athletic performance, bodybuilding, or cosmetic growth.

The FDA specifically states that Increlex is not a substitute for growth hormone for approved GH indications.

For healthcare professionals and patients, accurate product identification is particularly important because the medicine requires appropriate diagnosis, dosing, monitoring, and management of potential hypoglycemia and hypersensitivity.

Frequently Asked Questions

What is Increlex 10 mg/mL?

Increlex 10 mg/mL is a prescription solution for injection containing mecasermin, recombinant human IGF-1. It is used for specific pediatric growth disorders associated with severe primary IGF-1 deficiency.

What is the active ingredient?

The active ingredient is mecasermin, a recombinant form of human insulin-like growth factor-1 (IGF-1).

What is Increlex prescribed for?

It is prescribed for growth failure associated with severe primary IGF-1 deficiency in appropriately diagnosed pediatric patients. U.S. labeling also includes certain patients with growth hormone gene deletion who have developed neutralizing antibodies to GH.

Is Increlex a prescription medicine?

Yes. Increlex is a prescription medicine and treatment should be supervised by an appropriately qualified physician experienced in pediatric growth disorders.

How is Increlex administered?

It is administered by subcutaneous injection. The injection site should be rotated, and the medicine should be used according to the prescribing physician’s instructions.

Can Increlex be used for bodybuilding or athletic performance?

Increlex is not approved for bodybuilding, athletic performance, cosmetic purposes, or general growth enhancement. Its approved use is for specific medical indications involving severe primary IGF-1 deficiency

Introduction to Increlex: Unveiling a Growth Revolution:

Increlex (mecasermin) is a prescription medication that contains recombinant human insulin-like growth factor-1 (IGF-1). It is used for the treatment of a rare medical condition known as growth hormone insensitivity syndrome (GHIS), also referred to as insulin-like growth factor-1 deficiency (IGFD).

Generic Name: Mecasermin

Brand name: Increlex

GHIS is a genetic disorder characterized by a lack of response to growth hormone (GH), which leads to short stature and poor growth in affected individuals. Normally, GH is produced by the pituitary gland and stimulates the production of IGF-1 in the liver. IGF-1 plays a crucial role in promoting the growth and development of bones, muscles, and other tissues.

However, individuals with GHIS have a defect in the GH receptor or related signaling pathways, which results in reduced production of IGF-1 and impaired growth. Increlex, being a form of recombinant IGF-1, can help address this deficiency and promote linear growth in children with GHIS.

Key points about Increlex:

Indication: Increlex is indicated for the long-term treatment of children with growth failure due to severe primary IGF-1 deficiency (GHIS/IGFD) or with GH gene deletion who have developed neutralizing antibodies to GH.

Administration: Increlex is administered by subcutaneous (under the skin) injection. It is usually given once or twice daily, depending on the specific treatment plan recommended by the healthcare provider.

Monitoring: Regular monitoring of growth and IGF-1 levels is essential to adjust the dose and ensure optimal treatment outcomes.

Adverse Effects: Like any medication, Increlex can have side effects. Common side effects may include injection site reactions, headaches, and low blood sugar (hypoglycemia). Your doctor will monitor for these and other potential side effects.

Contraindications: Increlex should not be used in individuals with a known hypersensitivity to mecasermin or any of its components.

Usage in Athletes: It’s important to note that IGF-1, including Increlex, has been abused by some athletes and bodybuilders for its potential to enhance muscle growth and performance. However, such use is not approved and can lead to serious health risks.

Equines Vet: Your Trusted Online Source for Increlex

Equines Vet, your premier destination for purchasing Increlex online. We understand the importance of reliable and convenient access to quality medications for your pet’s health needs. Whether you’re seeking Increlex to address growth hormone deficiencies or other veterinary requirements, we’re here to ensure a seamless and secure shopping experience.

Why Choose Equines Vet for Increlex?

Trusted Expertise: With years of experience in the veterinary pharmaceutical industry, we are your knowledgeable partner in animal health.

Authenticity Guaranteed: Our Increlex products are sourced directly from reputable manufacturers, ensuring authenticity and effectiveness.

Convenience at Your Fingertips: Our user-friendly online platform allows you to buy Increlex from the comfort of your home, eliminating the hassle of traditional pharmacy visits.

Increlex for sale today from Equines Vet:

Elevate your pet’s well-being with Increlex from Equines Vet. Browse our selection, place your order, and rest assured that you’re providing the best care for your furry companion’s health and growth needs.

Please note that Increlex is a prescription medication, and you should consult a qualified veterinarian before administering it to your pet. Equines Vet encourages responsible and informed pet healthcare decisions.